Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

Journal of hepatology - 1 Jul 2000

Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Malé P J, Mentha G, Spahr L, Zarski J P, Borisch B, Hadengue A, Negro F

Abstract excerpt

BACKGROUND/AIMS: Patients infected with the hepatitis C virus (HCV) often have liver steatosis, suggesting the possibility of a viral cytopathic effect. The aim of this study was to correlate the occurrence and severity of liver steatosis with HCV RNA type, level and sequence of the core-encoding region. METHODS: We scored the liver steatosis in 101 HCV-infected individuals carefully selected to exclude other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Fatty Liver
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunocompetence

Share to Interferon-alpha

Share to Liver Cirrhosis

Share to Liver Transplantation

Share to Nucleocapsid Proteins

Source

Identifiers

PMID: 10905593
DOI: 10.1016/s0168-8278(00)80166-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.PMID 10905593Read ↗

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.Semantic proximity Read ↗

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.Semantic proximity Read ↗

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.Semantic proximity Read ↗

HCV liver infection and liver steatosis: evidence for indirect mechanisms in genotype 3?Semantic proximity Read ↗

Steatosis in chronic hepatitis C: why does it really matter?Semantic proximity Read ↗

Hepatitis C virus diversity and hepatic steatosis.Semantic proximity Read ↗

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.Semantic proximity Read ↗

Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis.Semantic proximity Read ↗

Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks.Semantic proximity Read ↗

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.Semantic proximity Read ↗

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.Semantic proximity Read ↗

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.